Consumer group calls on AstraZeneca to pull Crestor ads

Share this article:
Consumer advocacy group, Public Citizen, is calling on AstraZeneca to pull its latest newspaper ads for Crestor, charging that the ads make false claims about FDA's  concerns over the drug's safety.
"I urge that the FDA immediately stop AstraZeneca from running this or any other misleading advertising about Crestor," wrote Public Citizen's health research group director, Sidney Wolfe, in a letter sent to the FDA's acting commissioner, Lester Crawford, last week.
"The FDA has confidence in the safety and efficacy of Crestor," states  the full-page, color ads that began appearing in The New York Times, USA Today and The Wall Street Journal earlier this month, soon after a veteran FDA scientist named the drug as one of five currently marketed drugs that need more scrutiny.
However, the ad claims that the "concerns that have been raised have no medical or scientific basis."
Calling Public Citizen's concerns "absurd," an AstraZeneca spokesman told Reuters, "We've been assured at the highest level of the FDA that there are no new concerns with Crestor."
Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.